5.29 Potential of AFX-2, a Unique, Polysaccharide-Based Toll-like Receptor Agonist, in Patients With Chronic Lymphocytic Leukemia Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2011